Presentation: Adjustment Of Antidiabetic Doses Based On Creatinine Clearance And Its Relation With Glycemic Control In Type 2 DM Patients With Chronic Kidney Disease

Simple item page
dc.creatorEmy Oktaviani
dc.creatorEma Nillafita Putri Kusuma
dc.creatorAstri Fitrilia
dc.date2020-11-22
dc.date.accessioned2023-09-07T09:44:11Z
dc.date.available2023-09-07T09:44:11Z
dc.descriptionThis material presented in 2nd ICIGR 2020
dc.identifierhttps://zenodo.org/record/4284660
dc.identifier10.5281/zenodo.4284660
dc.identifieroai:zenodo.org:4284660
dc.identifier.urihttps://dspace.umsida.ac.id/handle/123456789/30539
dc.relationdoi:10.5281/zenodo.4284659
dc.relationurl:https://zenodo.org/communities/icigr2020
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by/4.0/legalcode
dc.titlePresentation: Adjustment Of Antidiabetic Doses Based On Creatinine Clearance And Its Relation With Glycemic Control In Type 2 DM Patients With Chronic Kidney Disease
dc.typeinfo:eu-repo/semantics/lecture
dc.typepresentation
Files
Collections
ICIGR 2020